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Endothelial Dysfunction Precedes Development of 
Microalbuminuria in IDDM
Coen D.A. Stehouwer, H.R. Andreas Fischer, Arno W.R. van Kuijk, Bettine C.P. Polak, 
and Ab J.M. Donker
In patients with insulin-dependent diabetes niellitus 
(IDDM), microalbuminuria is a predictor of widespread 
severe microangiopathy and maeroangiopathy. Patients 
with microalbuniimiria show generalized dysfunction of 
tiie vascular endothelium, but it Is unknown whether 
endothelial dysfunction precedes the development of mi­
croalbuminuria. We examined a cohort of 17 IDDM pa­
tients at baseline and on three occasions during a 
follow-up of (median) 64 months (range 51-89). All had 
normal (<15 fxg/min) urinary albumin excretion (UAE) 
at the iirst three examinations, At the fourth examina­
tion, 11 patients had normal UAE and 6 had microal­
buminuria (median 25,7 jxg/min [range 15,3-42.8]), 
Compared with patients with normal UAE, microalbumin- 
uric patients had significantly higher plasma levels of von 
Willebrand factor (vWF), a marker of endothelial dys­
function, at the second (200% [168-274] vs. 131% [69- 
186]), third (208% [188-270] vs, 125% [82-190]), and 
fourth examinations (231% [202-269] vs, 132% [88-208], 
JP < 0.0001), but not at baseline (128% [98-161] vs* 122% 
[87-210]). An increase in vWF preceded the occurrence of 
microalbuminuria by - 3 years. The groups did not differ 
with regard to age, diabetes duration, blood pressure, 
mean glycated hemoglobin and cholesterol, smoking hab­
its, or extent of retinopathy* Endothelial dysfunction, as 
estimated by plasma vWF concentration, precedes and 
may predict the development of microalbuminuria in 
IDDM. Diabetes 44:561-564, 1995
permeability, the balance between coagulation and fibrino­
lysis, the composition of the subendothelial matrix, and the 
mitogenesis of vascular smooth muscle and renal mesangial 
cells (4-6). In cross-sectional studies in IDDM, there is a 
close association between microalbuminuria and endothelial 
dysfunction. Thus, in patients with microalbuminuria, the 
vascular endothelium tends to increase, rather than de- 
erease, vascular resistance (7,8); fails to restrict the passage 
of macromolecules (1,3); and loses its anticoagulant and 
profibrinolytic properties (9,10). In addition, there is an 
increase in the plasma concentration of markers of endothe­
lial injury and dysfunction, such as von Willebrand factor 
(vWF) (9,11), a glycoprotein involved in primary hemostasis 
and secreted mainly by endothelial cells.
Some aspects of endothelial function have been reported 
to be disturbed in IDDM patients with normal urinary 
albumin excretion (UAE) (12-15), but whether these are of 
prognostic significance is not known. Answering that ques­
tion is important because it would increase our knowledge 
about the pathogenesis of microalbuminuria and allow early 
recognition of high-risk patients. Therefore, we wished to 
investigate whether endothelial dysfunction precedes the 
occurrence of microalbuminuria. To do this, we followed a 
group of IDDM. patients and measured UAE and plasma vWF 
concentration at regular intervals (as an estimate of endo­
thelial function).
n insulin-dependent diabetes mellitus (IDDM), mi­
croalbuminuria predicts the development not only of 
diabetic nephropathy, but also of severe retinopathy, 
neuropathy, hypertension, and macro vascular disease 
(1,2). Microalbuminuria is thought to be a marker of wide­
spread vascular damage (1,3), which may underlie the pro­
pensity of microalbuminuria patients to develop severe 
extrarenal vascular disease.
The endothelium is mi important locus of control of 
vascular functions. It actively regulates vascular tone and
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RESEARCH DESIGN AND METHODS
Cohort study. Between June 1985 and August, 1989, 05 IDDM pat ients 
(fasting ( ’»peptide levels <  0.01 nntol/1) were recruited and gave 
informed consent, as previously reported (11,12). Clinical and labora­
tory data, as detailed below, were obtained at baseline (first examina­
tion) and after a median follow-up of;} years (second examination). This 
study was completed in 59 patients and showed that the development of 
microalbuminuria was paralleled by increases in the plasma vWF 
concentration, but we could not. determine whether such increases 
preceded the occurrence of microalbuminuria (11). To further investi­
gate the time course of the development of complications of diabetes in 
relation to changes in vWF, patients were invited for further follow-up 
examinations when, at; the second examination, they had normal UAE, 
no diabetic retinopathy on ophthalmoscopy, and fair glyeemie control 
(HbAk. <  8.5%) and used no medication other than insulin (12). Patients 
with poorly controlled diabetes were excluded to avoid, as much as 
possible, fluctuations of plasma vWF concentrations associated with 
short-term changes in glyeemie control (16). Seventeen patients fulfilled 
these criteria and underwent third and fourth examinations, which are 
the subjects of this report. The median follow-up in these patients was 
24 months (range 11-47), 40 months (27-04), and (54 months (51-89) 
between the first and the second, the first, and the third, mid the first and 
the fourth examinations, respectively.
Clinical and laboratory  studies. Detailed descriptions are given 
elsewhere (11,12,17). At; each examination, we recorded age, diabetes 
duration, body mass index (BMI), blood pressure (BP; diastolic phase V, 
to the nearest 5 nunilg; twice, after 15 min of .supine rest, using a
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standard sphygmomanometer with an appropriately sized cuff), insulin 
dose, current smoking habits, and current medication. After an over­
night last, blood was drawn from an antecubital vein for measurement 
of glucose (glucose oxidase method), vWF antigen (see below), glycated 
hemoglobin (spectropho tome trie assay; Bio-Rad, Richmond, VA; normal 
range 3.5-6..5%), serum creatinine concentration (modified Jaffe reac­
tion), and serum total cholesterol (enzymatically; Bochringer Mann­
heim, Mannheim, Germany). Within 2 months of each examination, data 
on UAE and retinal status had been collected for all patients (see 
below).
Main outcome measures
UAE. On the basis of the median UAE in at least three consecutive 4-h 
(0800-1200) urine collections, patients were classified as having normal 
(<15 jjig/min) or increased UAE. Note that median values are reported, 
which minimizes the influence of occasional outliers. Microalbuminuria 
was defined (in advance [11,12]) as UAE of 15-200 (xg/min. (We chose 15 
fxg/min as cutoff because the median UAE in healthy volunteers in our 
laboratory is 5.7 jxg/min, with >95% having an UAE <15 jxg/min [11].) 
Patients were instructed to avoid strenuous exercise and to empty their 
bladders completely on arising and at noon. Completeness of urine 
collections was checked by comparing creatinine excretion among 
samples, whereas absence of infection was ensured by examining 
urinary sediments; new urine was collected when necessary. 
R e t in o p a th y . At the first and second examinations, the ocular fundus 
was examined by an ophthalmologist after dilatation of the pupils. At the 
third and fourth examinations, ophthalmoscopy was repeated on each 
patient by two ophthalmologists. In addition, fluorescein angiograms 
were obtained after intravenous injection of 5 ml 10% sodium fluores­
cein.
E n d o th e lia l  fu n ction .  Plasma vWF antigen concentration was mea­
sured by immimoelectrophoresis (11). The intra-assay and intevassay 
variations were 4.1 and 8.7%, respectively; the same assay was used 
throughout the study. Levels of and changes in vWF were expressed ¿is 
percentages of normal pooled plasma, the antigen level of which is 
defined sis 100% (normal range 50-150; 100% = 1.00 lU/ml). We were 
careful to avoid increases in vWF associated with hypoglycemia, exer­
cise, smoking, prolonged (>2  min) venous occlusion, and intercurrent 
illness. In our experience, the within-person day-to-day variability of 
plasma vWF was thus reduced to —10%.
The clinical and laboratory data, including UAE and retinal status, 
were collected without knowledge of the results of the vWF measure­
ments.
S ta tis tica l analysis. Data are presented as means ± SD or as medians 
and ranges, unless otherwise indicated. Patients were divided into two 
groups according to the absence or presence of increased UAE at the 
fourth examination. These groups were then compared with regard to 
clinical and laboratory characteristics and changes therein at examina­
tions 1-4, using standard parametric and nonparametric testing as 
indicated. A similar procedure was followed with the absence or 
presence of retinopathy as the outcome of interest. Finally, correlation 
analysis was used to study the relationship between (changes in) vWF 
levels and potential determinants of endothelial injury. All testing was 
two-sided. P values <0.05 were considered statistically significant.
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RESULTS
All 17 patients completed the study, except 1 refused fluo­
rescein angiography at the third examination and another 
declined both ophthalmoscopy and angiography at the 
fourth. There was no clinical evidence of macrovascular 
complications in any patient at the third examination, hut at 
the fourth, one patient (with normal UAE) had had a stroke, 
as confirmed by chart review, There were only two smokers 
among the patients; this factor was therefore omitted from 
further analyses. In one patient with persistently normal 
UAE, antihypertensive medication (a |3-receptor antagonist) 
was staited between the third and fourth examinations. 
UAE. At the fourth examination, 11 patients had normal UAE 
(7.2 [3.1-9.9] fxg/min) and 6 had microalbuminuria (25.7 
[15.3-42,8] (xg/min) (Fig. 1). Thus, the cumulative incidence 
of microalbuminuria was 35%, yielding an incidence density 
(cases per 100 person-years of follow-up) of 6.3. The main 
difference between the groups with normal versus increased
40
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FIG. 1. Time course of UAE and plasma vWF in patients with normal 
UAE (*) and microalbuminuria ( • )  at the final follow-up. A: seattertfram
of UAE (* and • )  and medians of vWF (*— — ■* and * -----• ) .  II: vWF
(normal range 50-150% [0.50-1.50 IU/ml|).
UAE was the plasma vWF concentration (Table 1 and Fig. 1), 
which was higher in the microalbuminuric patients at the 
second (median 200% (range 168-2741 vs. 131% [69-186]), 
third (208% (188-270) vs. 125% [82-190]), and fourth exami­
nations (231% [202-269] vs. 132% [88-2081, P < 0.0001 by
analysis of variance [ANOVA] and by Student's t tests), but 
not at baseline (128% [98-161] vs. 122% [87-210]). UAE at the 
fourth examination was related to both the plasma vWF level 
(r = 0.70, P = 0.002) and the change in plasma vWF between 
examinations 1 mid 4 (r = 0.80, P < 0,0001). A plasma vWF 
level above the upper limit of normal (i.e., 150%) at two or 
more of the first three examinations predicted the presence 
of microalbuminuria at the fourth examination with 100% 
sensitivity (6 of 6) and 82% specificity (9 of 11). These results 
were not materially altered by exclusion of the patient who 
received antihypertensive treatment or by exclusion of the 
two smokers.
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TABLE 1
Clinical and laboratory data for patient« with ID DM
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Sex (M/W)
Age (years)
Diabetes duration (years) 
Follow-up duration 
BMI (kg/nr)
*r
Blood pressure (mmllg)
First examination 
Second examiiiation 
Third examination 
Fourth examination 
Mean
Sc nun total cholesterol (nunol/1) 
Fi rs t/s e c o nd e xam in atio n 
Third/fourth examination 
Glycated hemoglobin (%) 
First/second examination 
Third/fourth examination 
Mean
Serum creatinine (|xmol/l) 
Diabetic retinopathy (yes/no)
<>py
FIuorescein angiography
JC
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Normal UAE
-•f I V V«.* — '••T^  • r~*. ► ••
5/6 
49 ± 13 
16 ± 3 
64 (51-85) 
24.2 ± 3.2 
1/10
139/84 ± 
132/81 ± 
135/83 ± 
146/83 
138/83
24/6
19/6
15/4
25/7
19/4
6.2 ± 0.8/6.3 ± 0.7 
6.1 ± 0.7/5.6± 1.3
8.0 ± 1,0/6.9 ± 0.8 
6.7 ± 0.8/7.5 ± 1.9 
7.2 ± 0.9 
80 ±  7
4/7
8/3
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Data are number of patients, means ± SD, or medians (ranges) at the fourth examination.
-- -
Microalbuminuria
3/3 
47 ± 19 
14 9 
67 (54-89) 
23.9 ± 2.4 
1/5
140/83 ± 28/15 
142/85 ± 21/10 
145/85 ± 15/9 
140/83 ± 16/5 
140/84 ± 19/8
6.0 ±  0,8/6.1 ±  0.7 
5.9 ±  0.7/5.8 ±  0.8
8.4 ±  1.3/6.8 ±  1.3 
6.7 ±  1.0/6.6 ±  0.7 
7.0 ±  0.9 
77 ±  8
3/2
3/2
Retinopathy, At the fourth examination, retinopathy was 
absent on ftmdoscopy in nine patients and present in seven. 
When angiography, a more sensitive method, was used as the 
criterion, retinopathy was absent in 5 patients and present in 
ll. Retinopathy was mild and consisted of microaneurysms 
(in nine patients), small hemorrhages (in five patients), and 
dilated capillaries (in seven patients; angiographic data). No 
patient had proliferative changes. Patients in whom retinop­
athy was absent on fundoseopy did not differ from those in 
whom it was present with regard to follow-up duration, sex 
distribution, age, diabetes duration, BMI, or serum creatinine 
at the fourth examination. In addition, ANOVA indicated no 
differences, at examinations I—4, in UAE, glycated hemoglo­
bin, serum cholesterol, or systolic and diastolic BP. Plasma 
vWF was also similar (124% [98-210] vs. 122% [87-170], 135% 
[101-200] vs. 145% [09-274], 140% [102-210] vs. 140% [82- 
270], and 139% [112-237] vs. 186% [88-209], respectively). 
Analysis of the angiographic data yielded similar results. 
vWF, vWF and the change in vWF were related to UAE (see 
above) but not to potential determinants of endothelial 
injury, such as age, diabetes duration, glycated hemoglobin, 
BP, and serum cholesterol. Similarly, vWF was not related to 
the blood glucose concentration at the time of blood sam­
pling, which varied between 3.6 and 16.9 mmol/1.
DISCUSSION
This study supports the hypothesis that the vascular endo­
thelium is an early and relevant target in the pathogenesis of 
diabetic  ^ microangiopathy. Endothelial dysfunction, as esti­
mated by plasma vWF concentration, preceded the develop­
ment of microalbuminuria in IDDM by as much as 3 years. In 
accordance with an earlier report (12), vWF levels were not 
related to the development of early diabetic retinopathy, 
which suggest« that retinal endothelial injury is not accom­
panied by widespread endothelial dysfunction resulting in 
increases in vWF.
Endothelial dysfunction in microalbuminuric IDDM ap~
?
pears to be generalized in that it affects many aspects of 
endothelial function (1,3,7,9-11,13). In IDDM patients with 
normal UAE, however, endothelial dysfunction is more vari­
able, restricted in nature, and less severe (13). As a working 
hypothesis, we suggest that endothelial dysfunction in IDDM 
develops gradually, with sustained increases in plasma vWI 
and UAE as relatively advanced features.
The type of endothelial dysfunction reflected by increased 
vWF levels is particularly closely related to microalbumin­
uria not only in IDDM (11), but also in non-insulin-dependent 
diabetes mellitus (NIDDM) (13,17) and essential hyperten­
sion (18). Microalbuminuria reflects an increased transcap- 
illary passage of macromolecules (1), a phase that, in IDDM, 
is preceded by a clear and persistent increase in vWF levels, 
as shown by our study. Such data are not available for 
NIDDM or hypertension, although high vWF levels in NIDDM 
may similarly increase the risk of development of microalbu­
minuria and the risk of clinical cardiovascular disease once 
microalbuminuria is present (17). It is not clem', however, 
whether the prognostic value of vWF is related to its specific 
functions, i.e., enhancement of platelet adhesion and factor 
VIII availability, or whether it is simply a marker of endothe­
lial injury and dysfunction. Nevertheless, both UAE and vWF 
deserve consideration as clinically useful markers of vascu­
lar status.
Determinants of increases in vWF, i.e., of endothelial 
injury, were not identified. Increases in vWF are nonspecific 
with respect to the type of injury and can be induced by 
hypertension, smoking, hypercholesterolemia, hyperglyce­
mia, activation of coagulation, and cytokines (13,18,19). The 
pathogenesis of microalbuminuria is likely to involve hyper­
glycemia and an early rise in BP (1,3,20-22). Our study was 
small and excluded patients with poor glycemic control, 
thereby limiting the ability to find a relation between UAE or 
vWF and glycated hemoglobin (11) or BP (20-22). In addi­
tion, susceptibility to the development of diabetic nephrop­
athy (and presumably microalbuminuria) is thought to vary
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among individuals (23). Variability among individuals in the 
susceptibility to injury of the endothelium might play a role, 
and this would hamper the identification of determinants of 
endothelial injury in cohort studies. Finally, other factors not 
assessed in this study may be important, such as insulin 
resistance, hyperinsulinemia, dyslipidemia, and activation of 
coagulation (19,24-26).
Are our findings generalizable? Clearly, selection bias 
cannot be completely excluded in a small study such as this. 
On the other hand, the patients were not selected on the 
basis of plasma vWF; therefore, the relationship between 
UAE and vWF is unlikely to have been affected by selection 
bias. In addition, the incidence density of microalbuminuria 
observed (6.3 or 4.2 [4 of 17; Fig. 1] with 20 |xg/min [1,3,22] 
instead of 15 (xg/min as cutoff) is within the range reported 
by others (1,1-8.2 [20-22,27-31]). Finally, the exclusion of 
patients with poor glycemic control may have increased the 
within-person stability of plasma vWF levels. Thus, the 
applicability of our results to patients with poorly controlled 
diabetes is somewhat uncertain.
Nevertheless, a sustained increase in plasma vWF in 
patients with IDDM is associated with a high risk of devel­
opment of microalbuminuria. We suggest that such patients 
are candidates for intensified treatment of hyperglycemia 
and of rises in BP (even small ones).
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